| Value | ₹450.0 Cr |
|---|
NSE filing, NSE: BALRAMCHIN. Summary written from the filing by ALFA Finder's alert engine.
Balrampur Chini Mills Ltd: key numbers
- Share price
- ₹633.20
- Market cap
- ₹13,401 Cr
- Revenue (annual)
- ₹6,271 Cr
- Net profit (annual)
- ₹378.5 Cr
- P/E (TTM)
- 36.1×Sector 26.2×
- Promoter holding
- 42.79%-0.07% QoQ
- FII holding
- 8.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balrampur Chini Mills Ltd
All →Balrampur Chini Mills Board Meeting Date
Balrampur Chini Mills will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The board will also consider an interim dividend for FY 2026-27.
Balrampur Chini Mills Employee Stock Options
Balrampur Chini Mills Limited has granted 1,21,268 Employee Stock Appreciation Rights (ESARs) under its 2023 ESAR plan, with an exercise price of ₹721.25 per unit.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills Ltd has submitted its quarterly shareholding pattern report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Balrampur Chini Mills Annual General Meeting
Balrampur Chini Mills Limited held its 50th Annual General Meeting on September 16, 2026. The meeting approved the financial statements and the final dividend.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills has sent a reminder intimation to physical shareholders, requesting them to update their KYC details and claim unpaid dividends or shares as mandated.
Balrampur Chini Mills Business Update
BCML received a ₹75 Crore BioE3 grant from BIRAC/DBT for a 100 TPA PLA R&D facility at Kumbhi, UP. It will advance India's biopolymer innovation and commercialisation.
- Value
- ₹75.00 Cr
- From
- BIRAC / Department of Biotechnology, Government of India
- PLA Co-Polymer R&D facility capacity
- 100 TPA
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.